Pitt Shield

Non-invasive ultrasonic modulation of visual evoked response by GABA delivery through the blood brain barrier.

Authors: Constans C, Ahnine H, Santin M, Lehericy S, Tanter M, Pouget P, Aubry JF

GABA is an inhibitory neurotransmitter that is maintained outside the brain by the blood brain barrier in normal condition. In this paper we demonstrate the feasibility of modulating brain activity in the visual cortex of non-human primates by transiently permeabilizing the blood brain barrier (BBB) using focused ultrasound (FUS) coupled with ultrasound contrast agents (UCA), followed by intra-venous injection of GABA. The visual evoked potentials exhibited a significant and GABA-dose-depend decrease in activity. The effect of the sonication only (with and without UCA) was also investigated and was shown to decrease the activity 8.7 times less than the GABA-induced inhibition enabled by BBB permeabilization. Finally, the UCA harmonic response was monitored during sonication to estimate the level of stable cavitation (a signature of the effectiveness of BBB permeabilization) and to avoid damage due to inertial cavitation (the sonication was automatically shut down when this condition was detected). Our results extend the promise of the exploration and treatment of the brain using non-invasive, controllable, repeatable, and reversible neuromodulation.

Introduction

Purpose In this paper we demonstrate the feasibility of modulating brain activity in the visual cortex of non-human primates by transiently permeabilizing the blood brain barrier (BBB) using focused ultrasound (FUS) coupled with ultrasound contrast agents (UCA), followed by intra-venous injection of GABA
Study Objective Use FUS and UCA to open the BBB for permiabiliity and deliver GABA.
Animal model / Human subject Two 6-year-old captive-born macaques (Macaca mulatta ‘A’ and ‘B’), weighing respectively 8 and 10 kg
Disease model healthy
MRI or image guidance method stereotaxic. MRI was performed with a 3T magnet (Prisma, Siemens, Germany) using an 8-channel receive only head coil specifically designed for non-human primate experiments (Life Services LLC, USA).
Targeted brain region(s) Middle Of Visual Corte (V1)
Target coordinates Did not specifically mentioned
Cargo name and characteristics GABA (0.1 to 6 mg/kg)
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes This studies shows the feability of modulating activity in the visual cortex of two non-human primates by delivering GABA with transient permeabilization of the blood brain barrier using focused ultrasound coupled with ultrasound contrast agents.
Duration of biological effect Each GABA injection sequence last for about 5 mins.
Safety-related matter Passive acoustic monitoring during BBB permeabilization has been investigated by Arvanitis et al [D. Arvanitis, M. S. Livingstone, N. Vykhodtseva, and N. McDannold,“Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring,” PLoS ONE, vol. 7, no. 9, art. no. e45783, 2012.]. The study was performed at 220kHz, which is similar to the frequency used in our study (245kHz). Arvanitis et al did not report any damage for broadband emission with a signal to noise ratio (SNR) lower than 4.3. We measured here a mean broadband emission SNR of 1.53±0.45 and a maximum SNR of 2.20. The maximum SNR is thus lower than the threshold for safe BBB permeabilization reported by Arvanitis et al.

Brain Region

Ultrasound Parameters

Ultrasound instrument Single element FUS transducer (H117, Sonic Concept Bothell, WA, USA) with a cavitation detector (PCD) at its center (Y107, Sonic Concept Bothell, WA, USA)
FUS Frequency 245kHz
FUS Intensity ISPPA: 9.7W/cm2 (in brain) ISPTA: 194mW/cm2 (behind the primate skull)
FUS Pressure 0.51MPA
FUS Mode pulsed
Pulse duration 20ms
Duration of a single FUS session 200 seconds
Focal Characteristics Transducer: diameter: 64mm 20mm central opening, F=1 Passive cavitation detector: at the center of transducer, 17.5mm active diameter, 64mm geometric focus,10kHz to 20MHz bandwidth
Treatment frequency ???

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search